Why it Matters

The Catholic health giant, Providence Health & Services, maintains its two-decade lobbying presence as Congress considers sweeping changes to Medicaid payment structures. Recently, the organization spent $140,000 in Q2 2025 on in-house advocacy. The timing is critical as bipartisan lawmakers scrutinize Medicare Advantage overpayments and prior authorization burdens.

By the Numbers

  • Current Quarter:
    – In-house lobbying: $140,000
    – External firms: $0
    – Lobbyist: Jacquelyn Alamia Bombard
  • Historical spending:
    – Total since 2003: $16.87 million
    – In-house program: $13 million across 68 disclosures
    – External firms: $3.83 million

Broader Context

Congress is actively considering legislation that could reshape hospital finances. Site-neutral payment reforms threaten facility fee revenues for integrated health systems. Medicare Advantage plans face mounting criticism for overpayments compared to traditional Medicare. Safety-net providers, like Providence, depend heavily on government reimbursement programs.

The Agenda

Providence targets Medicaid funding and Medicare Advantage programs specifically. The focus aligns with the health system’s role serving “poor and vulnerable” populations. Recent congressional hearings highlighted MA prior authorization delays that strain hospital resources. Providence executives have testified publicly about potential Medicaid cut impacts.

Competitive Landscape

Other major hospital systems and provider associations share Providence’s concerns. The American Hospital Association recently met with lawmakers about Medicare and Medicaid support. Health plans like UCare also lobbied on similar Medicaid and ACA marketplace priorities.

Between The Lines

Providence’s executive was invited by Rep. Mike Thompson to highlight Medicaid protection needs. The Health Care Fairness for All Act threatens current Medicaid financing with per-beneficiary caps. Bipartisan bills like the Prompt and Fair Pay Act would require MA plans to match traditional Medicare rates.

Recent hearings by House Ways & Means subcommittees exposed MA overpayments and prior authorization problems. Senators from both parties oppose Medicaid cuts that would hurt safety-net hospitals.

The Bottom Line

Providence maintains steady lobbying investment while facing significant policy headwinds. Congressional appetite for Medicare Advantage reform creates both opportunity and uncertainty. The health system’s advocacy reflects broader industry concerns about payment adequacy and regulatory burdens.

Spot something wrong? Report an issue with this article